carboxylic-acids-and-derivatives - carboxylic-acids-and-derivatives Manufacturer Supplier Exporter

bulk
Price

Supplier Type

Manufacturer
Trader
Reagent
contract manufacturer
custom synthesis

Supplier Region

Hyderabad(12)
Andhra Pradesh(2)
Bangalore(1)
Telangana(1)
Maharashtra(25)
Gujarat(24)
New Delhi(3)
Haryana(4)
Mumbai(49)
Vadodara(14)
Delhi(6)
Tamil Nadu(2)
Uttar Pradesh(6)
Ahmedabad(7)
Pune(4)
Karnataka(1)
West Bengal(1)
Madhya Pradesh(1)

Purity

United States Pharmacopeia (USP) Reference Standard
technical, ~90% (GC)
technical
ReagentPlus?, ≥99%
ReagentPlus?, 99%
Pharmaceutical Secondary Standard
PESTANAL?, analytical standard
Min. 99%
Min. 98%
Min 99.5%
Greater than 99%
for synthesis
for analysis EMSURE? ACS,Reag. Ph Eur
for analysis EMSURE? ACS
for analysis EMPARTA? ACS
European Pharmacopoeia (EP) Reference Standard
EMPLURA?
contaning 100ppm MEHQ inhibitor 99% (GC)
contaning 100ppm MEHQ inhibitor 98.00%
contains 50-100?ppm MEHQ as inhibitor, 98%
contains 250?ppm MEHQ as inhibitor, 99%
contains 10-20?ppm MEHQ as inhibitor, 99%
contains ≤30?ppm MEHQ as inhibitor, 99%
contains <200?ppm monomethyl ether hydroquinone as inhibitor, 98%
certified reference material, 1000?μg/mL in methanol
Certified Reference Material
buffer substance MPS
British Pharmacopoeia (BP) Reference Standard
BioXtra, ≥99%
BioUltra, for molecular biology, ≥99.0%
BioUltra, for molecular biology, ~5?M in H2O
battery grade, ≥99%, acid <200 ppm, anhydrous
average Mn ~912
average Mn ~428
anhydrous, free-flowing, Redi-Dri?, ReagentPlus?, 99%
anhydrous, for analysis EMPLURA?
anhydrous powder, EMPROVE? ESSENTIAL, Ph. Eur., BP, JP, USP, FCC, E 330
anhydrous fine-granular, EMPROVE? ESSENTIAL, Ph. Eur., BP, ChP, JP, USP, FCC, E 330
analytical standard
AldrichCPR
A.C.S. 99.5%
99+%
99.995%
≥99.99% trace metals basis
99.99% trace metals basis
99.99%
99.99
99.9% trace metals basis
99.9%
>99.8%(GC)
99.8%
99.7%
99.6%min
99.50%
>99.5%(GC)
99.5%
99.00%
>99.0%(T)
>99.0%(GC)(T)
>99.0%(GC)
99.0%
99%+
99%, contains ≤100?ppm monomethyl ether hydroquinone as inhibitor
99%, 1
99%
>99%
≥99%
99 atom % 13C
99 %
99
98+%
98+
98.50%
>98.0%(T)(N)
>98.0%(T)(HPLC)
>98.0%(T)
>98.0%(HPLC)
>98.0%(GC)(T)
>98.0%(GC)
≥98.0% (GC)
98.0%
98%+
≥98% palmitic acid basis (GC)
98% Min
≥98% (HPLC)
≥98%
>98%
98%
97-99%
97-99 %
>97.0%(T)
>97.0%(GC)(T)
>97.0%(GC)
≥97.0%
≥97% (titration)
97%
>97%
≥97%
96-98%
>96.0%(GC)
96.0%
96%
>95.0%(T)(HPLC)
>95.0%(T)
>95.0%(GC)(T)
>95.0%(GC)
≥95.0% (GC)
≥95%
95%
94-96%
>93.0%(GC)
>90.0%(GC)
90% min.
90%
85-90%
85%
85 %
60% , 85%
3-(N-Morpholino)propanesulfonic acid 98%
25 Kilograms
25 Kilograms
22%
14.5 - 16.0%
100%
1 Dram
(stabilised) for synthesis
(stabilised with hydroquinone monomethyl ether) for synthesis
(mixture of isomeres) for synthesis
(mixture of di-and triisocyanates) for synthesis
(mixture of cis- and trans isomers) for synthesis
&le
&ge